Help the right patientsfind the study.
What we make
Sites and patient communities use our recruitment films to enroll the right patients faster. Clear and human, made for studies that run across several countries.
Why trials stall on enrollment
Slow recruitment is the most expensive problem in a trial.
Fifty-five thousand, seven hundred and sixteen dollars.
Late-stage trials are billed by the day, so every week that recruitment drifts carries a price.
Tufts CSDD, 2024
Eighty percent.
Most trials miss the enrollment deadline they set themselves, and everything downstream slips with it.
Perspectives in Clinical Research, 2020
Up to thirty percent.
Finding patients can eat a large part of a development timeline before the science is ever tested.
Perspectives in Clinical Research, 2020
Sites that fall short of their enrollment target are common, and the study waits on them.
Tufts CSDD, 2013
Every day of delay burns budget. Most eligible people never hear about the study, or cannot tell if it fits their life. In rare disease there are fewer of them to find, and our guide to rare-disease storytelling explains how a film reaches them.
See the evidence.How film speeds up enrollment
We make two films that work at the site and inside patient communities: a recruitment film that reaches the right people, and an “is this study right for me?” film that helps them decide.
Every country in the study gets its own localized version, cleared through review.
Listen.
The site team talks us through the protocol first.
Patient burden, and the questions people ask.
Film.
Real people, with consent running the whole shoot.
No actors, and nobody hands a patient their lines.
Finish.
Graded and versioned for every country in the study.
Each language clears review from the same approved master.
You stay with the same experienced team the whole way.